The work described in this thesis involves developing synthetic methods to produce a range of drug-like small molecules that can be used as chemical tools to understand and modulate disease pathophysiology. There are two types of such tools investigated in this thesis: diagnostic tools for imaging experiments, and inhibitory tools for modulating biochemical pathways. The imaging tools are designed to target apoptosis, accumulating in cells undergoing early-stage apoptotic events, and contain a fluorescent tag, thus providing a realtime technique for observing and monitoring these events and even to modulate them from inside the cell. The imaging agent would then be used to guide the design of a radiolabelled small molecule that can be used alongside traditional cancer therapies, to preferentially enter cells going through apoptosis, ensuring that these cells commit to cell death and do not recover. The inhibitory tools are designed to study the molecular mechanisms of MK2, a protein that has been implicated in disease progression and cellular ageing events. This worked used the premature ageing syndrome, Werner's Syndrome as a model for normal human ageing. In Chapter 2, several fluorescent markers are considered for the development of a real-time imaging tool to target apoptosis. The structures of the fluorescent agents are based on two structures known to preferentially enter cells going through the early stages of apoptosis; didansyl cystine and ML10. The conclusion of this investigation led to ML10 being used as the basis for further development of fluorescent agents. The formation of several novel BODIPY compounds is described, with one compound tested in a cell line for its ability to preferentially enter cells going through the early stages of apoptosis. The results of this test led to an investigation into the lipophilicity of BODIPY compounds versus ML10. This investigation involved the use of software to generate cLogP values as a guide for potential designs of further BODIPY structures. The development of a drug-like structure that can mimic the action of the BODIPY compound is also explored, with the inclusion of a step to insert iodine-131 at a later stage in the development. In Chapter 3, microwave-assisted organic synthesis was used to develop novel routes toward benzothiophene derivatives, which formed part of a new route towards the Pfizer developed MK2 inhibitor PF-3644022. This work was published in Organic and Biomolecular Chemistry. The full route was proposed in the doctoral thesis of Dr. Jessica Dwyer, and the latter part of this thesis set out to improve the yield of the final step. A collaboration with the Kostakis group led to an investigation into the use of the catalyst Zn2Y2(C21H25NO3)4 for its applicability to the Doebnertype multi-component reaction that would lead to the formation of PF-3644022. Although no conclusive results were obtained from the reactions trialled, the work opened up new channels of collaboration for the Bagley group and potential for further exploration of the use of isoskeletal coordination cluster catalysts in organic multi-component reactions. Overall, the aim of this work was to deliver rapid routes to these chemical tools so that, through in vivo and in vitro biological studies, we can better understand the role of kinase targets during disease progression and therapy in healthy and diseased cells. In this context, this work establishes novel routes to new chemical tools, validates their identity and action, and explores their application in providing new insights into biochemical processes and new opportunities for chemical intervention in pathophysiological events.
| Identifer | oai:union.ndltd.org:bl.uk/oai:ethos.bl.uk:742161 |
| Date | January 2018 |
| Creators | Rand, Hayley Louise |
| Publisher | University of Sussex |
| Source Sets | Ethos UK |
| Detected Language | English |
| Type | Electronic Thesis or Dissertation |
| Source | http://sro.sussex.ac.uk/id/eprint/75958/ |
Page generated in 0.002 seconds